- Home
- SCPH vs MPV Comparison
SCPH vs MPV Comparison
Compare SCPH & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- MPV
- Stock Information
- Founded
- SCPH 2013
- MPV 1988
- Country
- SCPH United States
- MPV United States
- Employees
- SCPH N/A
- MPV N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- MPV Finance Companies
- Sector
- SCPH Health Care
- MPV Finance
- Exchange
- SCPH Nasdaq
- MPV Nasdaq
- Market Cap
- SCPH 173.6M
- MPV 171.3M
- IPO Year
- SCPH 2017
- MPV N/A
- Fundamental
- Price
- SCPH $2.57
- MPV $17.52
- Analyst Decision
- SCPH Strong Buy
- MPV
- Analyst Count
- SCPH 3
- MPV 0
- Target Price
- SCPH $14.00
- MPV N/A
- AVG Volume (30 Days)
- SCPH 519.0K
- MPV 25.2K
- Earning Date
- SCPH 05-13-2025
- MPV 01-01-0001
- Dividend Yield
- SCPH N/A
- MPV 8.71%
- EPS Growth
- SCPH N/A
- MPV N/A
- EPS
- SCPH N/A
- MPV 1.71
- Revenue
- SCPH $36,332,000.00
- MPV N/A
- Revenue This Year
- SCPH $114.00
- MPV N/A
- Revenue Next Year
- SCPH $77.45
- MPV N/A
- P/E Ratio
- SCPH N/A
- MPV $9.35
- Revenue Growth
- SCPH 167.28
- MPV N/A
- 52 Week Low
- SCPH $1.94
- MPV $11.18
- 52 Week High
- SCPH $5.65
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- SCPH 47.35
- MPV 65.00
- Support Level
- SCPH $1.94
- MPV $16.84
- Resistance Level
- SCPH $2.71
- MPV $16.88
- Average True Range (ATR)
- SCPH 0.27
- MPV 0.64
- MACD
- SCPH 0.04
- MPV 0.10
- Stochastic Oscillator
- SCPH 76.36
- MPV 81.86
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.